Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin Upon Low-Dose Photon Irradiation

Journal of the American Chemical Society - United States
doi 10.1021/jacs.9b11969
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Doxorubicin Cardiotoxicity and Target Cells: A Broader Perspective

Cardio-Oncology
2016English

Low-Molecular-Weight Polymer–drug Conjugates for Synergistic Anticancer Activity of Camptothecin and Doxorubicin Combinations

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2016English

Dose-Escalated Total-Marrow Irradiation (TMI) for Relapsed Multiple Myeloma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Non-Covalent Immunoproteasome Inhibitors Induce Cell Cycle Arrest in Multiple Myeloma MM.1R Cells

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Inhibition of Exosome Release by Ketotifen Enhances Sensitivity of Cancer Cells to Doxorubicin

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2017English

Modified Bacterial Cellulose Scaffolds for Localized Doxorubicin Release in Human Colorectal HT-29 Cells

Colloids and Surfaces B: Biointerfaces
SurfacesColloidInterfacesTheoretical ChemistryMedicineBiotechnologySurface ChemistryPhysical
2016English

Synthesis, in Vitro Stability, and Antiproliferative Effect of D -Cysteine Modified GnRH-doxorubicin Conjugates

Journal of Peptide Science
Organic ChemistryMolecular MedicinePharmacologyMolecular BiologyBiochemistryStructural BiologyMedicineDrug Discovery
2018English

Hepatocellular Carcinoma Cells Surviving Doxorubicin Treatment Exhibit Increased Migratory Potential and Resistance to Doxorubicin Re-Treatment In�vitro

Oncology Letters
Cancer ResearchOncology
2018English

A Phase I/Ii Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy